Disney attracting more eyeballs, but is it winning?
Disney attracting more eyeballs, but is it winning?
General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.
About this video
ResMed is out with its fourth quarter results, delivering solid sales and profit growth. The latter appearing to be ahead of the market's expectations. It reported quarterly adjusted earnings of $1.49 per share, while revenue rose 4.4% to $914.74 million from a year ago.
A key driver of its strong full year growth was the U.S., Canada, and Latin America segment which supported this with a 7% increase in sales.
The streaming market remains hotly contest globally with Disney+ adding 14.4 million subscribers quarter on quarter to surpass Netflix in viewing customers. However, as Ken Leon from CFRA points out, US domestic growth was nearly flat. He says its international business saw quarter on quarter growth of 6.1 million, excluding Disney+ Hotstar (India). Disney+ had a $1.1b operating loss, wider than -$887m in Q2 FY 22 and -$223m a year ago. Ken says Disney's decision to offer customers an ad-free subscription at a premium is an important development, with other streaming services also adopting the strategy. CFRA has raised its target on Disney by $20 to $130, while ken says with higher losses in direct-to-consumer unit, CFRA reduces its EPS estimates in FY 22 by $0.15 to $3.85.
More like this
5:08
Market Update | Apple, NVIDIA, Walt Disney, Bitcoin, SEEK, Bendigo and Adelaide Bank, Infratil, PEXATuesday · IFT, PXA, SEK52:50
the callthe call: 5th November | NU ISRG ADBE ADBE CMG TSLA RACE SNOW DIS UBER PYPL5 Nov 202659:22
the callthe call: 22nd October | MSFT GE V NFLX MNST SQM MRVL AS JNJ MCD22 Oct 20264:26
Market Update | Space Exploration Technologies Corp, Netflix, Woodside Energy, NEXTDC, Sigma Healthcare, Pro Medicus20 Oct 2026 · NXT, PME, SIG, WDS